WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients
Gilead Sciences Inc’s remdesivir had little or no effect on COVID-19 patients’ length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from bdnews24.com - Home https://ift.tt/3nTkP0d
from bdnews24.com - Home https://ift.tt/3nTkP0d
No comments